Bath & Body Works, Inc. (BBWI) Key Metrics

NYSE: BBWIValuation, returns, debt and efficiency ratios over 10 years.

BBWI valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$4.06B
Enterprise value
$7.41B
P/E (TTM)
5.3
10-yr median 11.1
Forward P/E
6.3
PEG ratio
0.70
Price / sales
0.6
10-yr median 1.1
Price / book
—
EV / EBITDA
5.0
10-yr median 7.4
Dividend yield
3.97%
$0.80 a year
Beta
1.40

BBWI key metrics, FY2017–FY2026

Fiscal year ended January 31, 2026 · U.S. dollars

BBWI valuation Price multiples at each fiscal year-end price.

P/E ratio−31.8%
7.1
FY2026 · hover or tap a bar for each year
FY2017: 12.2 (−33.5%)FY2018: 11.8 (−3.2%)FY2019: 9.7 (−18.5%)FY2021: 11.0FY2022: 11.5 (+4.7%)FY2023: 13.4 (+16.7%)FY2024: 11.1 (−17.0%)FY2025: 10.4 (−6.4%)FY2026: 7.1 (−31.8%)
FY2017FY2026
Price / sales−44.4%
0.6
FY2026 · hover or tap a bar for each year
FY2017: 1.1 (−40.6%)FY2018: 0.9 (−18.2%)FY2019: 0.5 (−49.0%)FY2020: 1.0 (+103.6%)FY2021: 1.4 (+50.5%)FY2022: 1.9 (+34.9%)FY2023: 1.4 (−27.0%)FY2024: 1.3 (−7.3%)FY2025: 1.1 (−13.5%)FY2026: 0.6 (−44.4%)
FY2017FY2026
EV / EBITDA−21.4%
6.1
FY2026 · hover or tap a bar for each year
FY2017: 6.9 (−28.5%)FY2018: 7.0 (+0.9%)FY2019: 5.8 (−16.7%)FY2020: 8.1 (+40.5%)FY2021: 6.3 (−22.0%)FY2022: 8.9 (+40.1%)FY2023: 9.6 (+8.2%)FY2024: 8.7 (−9.4%)FY2025: 7.8 (−10.9%)FY2026: 6.1 (−21.4%)
FY2017FY2026
Price / free cash flow−57.7%
5.3
FY2026 · hover or tap a bar for each year
FY2017: 15.7 (−22.1%)FY2018: 16.7 (+5.8%)FY2019: 8.3 (−50.1%)FY2020: 6.6 (−20.1%)FY2021: 5.1 (−23.0%)FY2022: 12.5 (+145.0%)FY2023: 13.1 (+4.9%)FY2024: 14.9 (+13.4%)FY2025: 12.6 (−15.4%)FY2026: 5.3 (−57.7%)
FY2017FY2026
Free cash flow yield+10.8 pts
18.8%
FY2026 · hover or tap a bar for each year
FY2017: 6.4% (+1.4 pts)FY2018: 6.0% (−0.3 pts)FY2019: 12.0% (+6.0 pts)FY2020: 15.1% (+3.0 pts)FY2021: 19.6% (+4.5 pts)FY2022: 8.0% (−11.6 pts)FY2023: 7.6% (−0.4 pts)FY2024: 6.7% (−0.9 pts)FY2025: 7.9% (+1.2 pts)FY2026: 18.8% (+10.8 pts)
FY2017FY2026

BBWI valuation history

Fiscal year-endToday10-year median

BBWI returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

BBWI debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

BBWI cash returned to shareholders

DividendsBuybacksFree cash flow

BBWI price vs earnings per share

Share price at year-endEPS (right axis)

BBWI key metrics

FY2017–FY2026
Bath & Body Works, Inc. key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$4.61B$8.31B$9.77B$10.72B$15.31B$9.26B$5.17B$6.22B$11.64B$14.17B
Enterprise value$8.61B$12.60B$14.26B$15.54B$19.34B$13.17B$12.75B$10.61B$15.92B$17.97B
P/E ratio7.110.411.113.411.511.0—9.711.812.2
Price / sales0.61.11.31.41.91.41.00.50.91.1
Price / free cash flow5.312.614.913.112.55.16.68.316.715.7
Price / operating cash flow4.29.410.29.410.34.54.24.58.37.5
EV / sales1.21.71.92.12.52.02.40.81.31.4
EV / EBITDA6.17.88.79.68.96.38.15.87.06.9
EV / free cash flow10.019.121.719.015.87.316.414.222.820.0
Earnings yield14.1%9.6%9.0%7.5%8.7%9.1%−7.1%10.4%8.4%8.2%
Free cash flow yield18.8%7.9%6.7%7.6%8.0%19.6%15.1%12.0%6.0%6.4%
Dividend yield3.6%2.1%1.9%1.7%0.8%0.9%6.4%10.7%5.9%9.0%
Shareholder yield (dividends + buybacks)12.3%7.0%3.4%14.0%13.6%1.0%6.7%13.9%9.7%12.0%
Share price at fiscal year-end$21.80$37.61$42.66$46.01$56.07$32.95$18.72$22.51$40.49$48.67
Per share
Revenue per share$34.45$33.06$32.44$32.45$28.87$22.90$19.58$47.93$43.95$43.20
Earnings per share$3.07$3.61$3.83$3.43$4.88$3.00−$1.33$2.33$3.42$3.98
Operating cash flow per share$5.21$4.01$4.17$4.91$5.47$7.26$4.48$4.99$4.89$6.49
Free cash flow per share$4.09$2.99$2.86$3.50$4.48$6.44$2.82$2.71$2.43$3.09
Cash per share$4.50$3.05$4.73$5.29$7.25$12.70$5.43$5.12$5.27$6.64
Book value per share−$6.04−$6.27−$7.10−$9.46−$5.56−$2.36−$5.43−$3.15−$2.62−$2.50
Tangible book value per share−$9.79−$9.86−$10.57−$12.87−$8.47−$5.18−$9.20−$9.52−$8.74−$8.55
Dividends per share$0.79$0.80$0.79$0.80$0.44$0.30$1.20$2.41$2.39$4.36
Capex per share$1.12$1.02$1.30$1.41$0.99$0.81$1.66$2.28$2.46$3.40
Debt per share$23.41$22.44$24.34$25.98$22.03$26.62$32.89$21.04$20.16$19.71
Shares outstanding211.6M221.0M229.0M233.0M273.0M281.0M276.0M276.2M287.4M291.1M
Change in shares outstanding−4.2%−3.5%−1.7%−14.7%−2.8%+1.8%−0.1%−3.9%−1.3%−1.9%
Returns & profitability
Return on invested capital (ROIC)29.5%34.1%40.3%40.7%52.6%26.5%16.4%26.4%39.2%45.7%
Return on assets (ROA)13.1%15.4%16.0%13.9%15.2%7.8%−4.0%7.9%12.0%13.9%
Return on tangible assets15.2%19.6%18.8%17.0%25.5%7.8%−4.0%10.2%15.4%18.1%
Free cash flow margin11.9%9.0%8.8%10.8%15.5%28.1%14.4%5.7%5.5%7.2%
Income quality (OCF / net income)1.701.111.091.431.122.42—2.141.431.63
Financial health
Total debt$4.95B$4.96B$5.57B$6.05B$6.01B$7.48B$9.08B$5.81B$5.79B$5.74B
Cash & short-term investments$953.0M$674.0M$1.08B$1.23B$1.98B$3.57B$1.50B$1.41B$1.51B$1.93B
Net debt$4.00B$4.29B$4.49B$4.82B$4.03B$3.91B$7.58B$4.40B$4.28B$3.80B
Debt / assets0.981.021.021.101.000.650.900.720.710.70
Net debt / EBITDA2.832.642.752.991.861.894.842.401.871.46
Current ratio1.271.481.641.642.331.971.371.641.621.72
Quick ratio0.830.881.091.131.781.770.831.011.011.18
Interest coverage4.14.13.74.05.23.72.83.24.35.1
Working capital$428.0M$592.0M$826.0M$887.0M$1.72B$2.75B$873.0M$1.27B$1.26B$1.45B
Invested capital$2.72B$2.90B$2.86B$2.62B$2.52B$3.25B$6.08B$3.53B$3.53B$3.07B
Tangible asset value−$2.07B−$2.18B−$2.42B−$3.00B−$2.31B−$1.45B−$2.53B−$2.62B−$2.51B−$2.49B
Net current asset value−$4.33B−$4.43B−$4.97B−$5.43B−$4.53B−$6.65B−$8.38B−$5.70B−$5.61B−$5.43B
Graham net-net per share−$23.21−$22.90−$23.94−$25.51−$18.42−$29.42−$33.51−$24.05−$22.73−$21.28
Capital allocation
Dividends paid$167.0M$177.0M$182.0M$186.0M$120.0M$83.0M$332.0M$666.0M$686.0M$1.27B
Share buybacks (net)$401.0M$401.0M$148.0M$1.31B$1.96B$12.0M$13.0M$198.0M$446.0M$435.0M
Dividend payout ratio25.7%22.2%20.7%23.2%9.0%9.8%—103.4%69.8%109.5%
Dividends + buybacks / free cash flow65.7%87.6%50.3%183.6%170.5%5.2%44.3%115.5%161.9%189.2%
Capex / revenue3.3%3.1%4.0%4.3%3.4%3.5%8.5%4.8%5.6%7.9%
Capex / operating cash flow21.5%25.5%31.2%28.7%18.1%11.2%37.1%45.7%50.3%52.4%
Capex / depreciation0.930.801.111.480.740.440.781.071.241.91
Stock-based compensation / revenue0.4%0.5%0.6%0.5%0.6%0.8%1.6%0.7%0.8%0.8%
SG&A / revenue28.3%26.9%26.3%24.9%23.4%23.2%24.9%26.9%25.6%24.8%
Efficiency
Days sales outstanding9.610.711.111.29.012.922.79.38.78.1
Days of inventory on hand63.864.761.860.158.1101.6153.354.555.654.3
Days payables outstanding35.732.236.337.735.354.282.131.333.333.1
Cash conversion cycle (days)37.743.236.533.631.760.393.932.531.029.3
Receivables turnover37.8834.0733.0232.4540.6328.3416.0639.1041.8345.31
Payables turnover10.2211.3510.049.6710.336.734.4411.6810.9611.03
Inventory turnover5.735.645.916.076.293.592.386.706.576.72
Asset turnover1.471.411.361.310.900.590.591.631.551.51
Average receivables$192.5M$214.5M$225.0M$233.0M$194.0M$227.0M$336.5M$338.5M$302.0M$277.5M
Average payables$401.5M$359.0M$417.5M$445.0M$390.0M$496.0M$679.0M$714.0M$700.0M$675.5M
Average inventory$716.5M$722.0M$709.5M$709.0M$640.5M$929.5M$1.27B$1.24B$1.17B$1.11B
Intangibles / total assets15.6%16.3%14.5%14.4%13.2%6.9%10.3%21.7%21.6%21.5%

Computed from BBWI's annual financial statements (latest annual report filed March 12, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

BBWI valuation and financial ratios

At the end of fiscal 2026 (January 31, 2026), Bath & Body Works traded at 7.1 times earnings, against a 10-year median of 11.1. Based on the latest twelve months, the trailing P/E is 5.3 and the forward P/E is 6.3. Bath & Body Works earned a return on invested capital of 29.5% in fiscal 2026. It ended the year with $5.0 billion of debt and $953.0 million in cash and short-term investments, net debt of $4.0 billion. It returned $568.0 million to shareholders: $167.0 million in dividends and $401.0 million in share buybacks, 66% of free cash flow. The share count fell 27.3% from 291.1M to 211.6M over 9 years.

See the BBWI income statement, the BBWI chart for price history, or the BBWI stock overview for the latest quote and news.

BBWI key metrics FAQ

What is Bath & Body Works's P/E ratio?

Bath & Body Works's trailing P/E ratio is 5.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 6.3. At the end of fiscal 2026 it was 7.1, compared with a 10-year median of 11.1.

What is Bath & Body Works's EV/EBITDA?

Bath & Body Works's enterprise value was 6.1 times EBITDA at the end of fiscal 2026 (enterprise value $8.6 billion, EBITDA $1.4 billion); the current EV/EBITDA is 5.0.

What is Bath & Body Works's ROIC?

Bath & Body Works's return on invested capital was 29.5% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Bath & Body Works have?

Bath & Body Works had total debt of $5.0 billion at the end of fiscal 2026 and $4.0 billion of net debt (2.83 times EBITDA).

What is Bath & Body Works's dividend yield?

Bath & Body Works's forward dividend yield is 3.97%. Bath & Body Works paid $167.0 million in dividends in fiscal 2026 ($0.79 per share), a payout ratio of 25.7%.

Does Bath & Body Works buy back its shares?

Yes. Bath & Body Works spent $401.0 million on net share repurchases in fiscal 2026 Shares outstanding changed −4.2% over the year, to 211.6M..

What is Bath & Body Works's free cash flow yield?

Bath & Body Works generated $865.0 million of free cash flow in fiscal 2026, a free cash flow yield of 18.8% on its market value at year-end ($4.6 billion).

What is Bath & Body Works's current ratio?

Bath & Body Works's current ratio was 1.27 at the end of fiscal 2026: current assets were 1.27 times current liabilities.

Specialty Retail key metrics